Anonymous ID: 55f738 Oct. 18, 2020, 7:37 p.m. No.11145481   🗄️.is 🔗kun   >>5502 >>5503 >>5514 >>5521 >>5567 >>5588

The more I think about this Hunter Biden laptop crap, the more pissed I become.

 

It's 2015 all over again, but worse.

 

2015 - FBI sat on Clinton criminal files to prevent Trump from becoming POTUS.

2020 - FBI sits on Biden criminal files DURING THE FRAUD IMPEACHMENT, hoping Trump was removed.

Now - FBI sits on Biden criminal files to again help prevent Trump from staying POTUS!

 

For 4 years Trump has been trying to drain the swamp, and we're no further along.

WTF?

And regardless how this pans out, no one in the Federal Bureau of Incompetence will be held accountable.

[They], along w/CIA, DOJ, NSA etc.) must be dismantled & reorganized with an outside oversight group (from outside DC or any major city) with arrest & proprietorial power whose sole job is to investigate & prosecute crimes within these agencies.

Anonymous ID: 55f738 Oct. 18, 2020, 7:51 p.m. No.11145685   🗄️.is 🔗kun   >>5977 >>5994

>>11145441

 

part 2

 

What the search engine is to Google, the Personal Genome Service is to 23andMe. The company is not exactly hiding its ambitions. “The long game here is not to make money selling kits, although the kits are essential to get the base level data,” Patrick Chung, a 23andMe board member, told FastCompany last month. “Once you have the data, [the company] does actually become the Google of personalized health care.” The company has lowered the price of the kit again and again, most recently from $299 to a mere $99, practically making it a stocking-stuffer. All the better to induce volunteers to give 23andMe the data it so desperately wants. (Currently, the database contains the genetic information of some half a million people, a number Wojcicki reportedly wants to double by year end.)

 

What does 23andMe want to do with all that data? Right now the talk is all about medical research—and, in fact, the company is doing some interesting work. It has been sifting through its genomic database, which is combined with information that volunteers submit about themselves, to find possible genetic links to people’s traits. (The bright-light/sneeze genetic tag is a 23andMe discovery.) More promising are 23andMe’s attempts to recruit people who suffer from certain diseases, such as Parkinson’s and a few types of cancer. Simply through brute-force pattern matching, the company has a chance of finding genetic causes of these ailments, which could lead to a way to combat them. (And perhaps a blockbuster patent or three.)

Anonymous ID: 55f738 Oct. 18, 2020, 7:52 p.m. No.11145700   🗄️.is 🔗kun   >>5977 >>5994

>>11145441

 

Part 3

 

That’s just the beginning, though. 23andMe reserves the right to use your personal information—including your genome—to inform you about events and to try to sell you products and services. There is a much more lucrative market waiting in the wings, too. One could easily imagine how insurance companies and pharmaceutical firms might be interested in getting their hands on your genetic information, the better to sell you products (or deny them to you). According to 23andMe’s privacy policy, that wouldn’t be an acceptable use of the database. Although 23andMe admits that it will share aggregate information about users genomes to third parties, it adamantly insists that it will not sell your personal genetic information without your explicit consent.

newsletter promo

 

Sign up for Scientific American’s free newsletters.

 

 

We’ve heard that one before. Back when Google was first launched, the founders insisted that the company would never sell you out to advertisers. The company admitted that it would share aggregate information about users’ behavior with anyone who ponied up enough money, but the company’s privacy policy promised that “[i]ndividually identifiable information about you is not willfully disclosed to any third party without first receiving your permission.” A decade and a half later, after countless minuscule frog-in-boiling-water changes, Google’s privacy policy is craftily worded, diluting the word “consent” so that it’s implicit in most cases. (There are a few exceptions; the company has graciously agreed not to reveal that you are a homosexual or that you have heart disease unless you explicitly opt in. But in matters not related to your medical conditions, race, ethnicity, sexuality, or your political or religious beliefs, there is no such guarantee.) Not that your consent really matters, implicit or explicit. Google has repeatedly proven that it is more than willing to break its promises and ignore its own privacy rules when it suits.

Advertisement

 

Why should we believe that 23andMe’s promises are any more binding? Early signs certainly aren’t encouraging. Even though 23andMe currently asks permission to use your genetic information for scientific research, the company has explicitly stated that its database-sifting scientific work “does not constitute research on human subjects,” meaning that it is not subject to the rules and regulations that are supposed to protect experimental subjects’ privacy and welfare.

 

Those of us who have not volunteered to be a part of the grand experiment have even less protection. Even if 23andMe keeps your genome confidential against hackers, corporate takeovers, and the temptations of filthy lucre forever and ever, there is plenty of evidence that there is no such thing as an “anonymous” genome anymore. It is possible to use the internet to identify the owner of a snippet of genetic information and it is getting easier day by day.

Anonymous ID: 55f738 Oct. 18, 2020, 7:53 p.m. No.11145713   🗄️.is 🔗kun   >>5977 >>5994

>>11145441

 

Part 4

 

This becomes a particularly acute problem once you realize that every one of your relatives who spits in a 23andMe vial is giving the company a not-inconsiderable bit of your own genetic information to the company along with their own. If you have several close relatives who are already in 23andMe’s database, the company already essentially has all that it needs to know about you. It is doubtful that 23andMe would be able to protect that information even if it were so inclined.

 

While the FDA concentrates on the question of whether 23andMe’s kit is a safe and effective medical device, it is failing to address the real issue: what 23andMe should be allowed to do with the data it collects. For 23andMe’s Personal Genome Service is much more than a medical device; it is a one-way portal into a world where corporations have access to the innermost contents of your cells and where insurers and pharmaceutical firms and marketers might know more about your body than you know yourself. And as 23andMe warns on its website, “Genetic Information that you share with others could be used against your interests. You should be careful about sharing your Genetic Information with others.”

 

Present company excepted, of course.